Clinical measures in transthyretin familial amyloid polyneuropathy

被引：53
|
作者：
Coelho, Teresa [1 ]
Vinik, Aaron [2 ]
Vinik, Etta J. [2 ]
Tripp, Tara [3 ]
Packman, Jeff [4 ]
Grogan, Donna R. [4 ]
机构：
[1] Hosp Santo Antonio, Ctr Hosp Porto, P-4099001 Oporto, Portugal
[2] Eastern Virginia Med Sch, Strelitz Diabet Ctr, Norfolk, VA 23501 USA
[3] DM Stat Inc, Malden, MA USA
[4] FoldRx Pharmaceut Inc, Cambridge, MA USA
来源：
MUSCLE & NERVE | 2017年 / 55卷 / 03期
关键词：
amyloidosis; modified body mass index; nerve fiber function; Neuropathy Impairment Score; Norfolk Quality of Life; ROCHESTER DIABETIC-NEUROPATHY; RETINOL-BINDING-PROTEIN; LIVER-TRANSPLANTATION; FOLLOW-UP; PERIPHERAL NEUROPATHY; END-POINTS; TAFAMIDIS; SURVIVAL; TRIAL; DYSFUNCTION;
D O I：
10.1002/mus.25257
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IntroductionThis observational, cross-sectional, single-center study aimed to identify instruments capable of measuring disease progression in transthyretin familial amyloid polyneuropathy (TTR-FAP). MethodsThe relationship between disease stage and Neuropathy Impairment Score-Lower Limbs (NIS-LL) and Norfolk Quality of Life-Diabetic Neuropathy (Norfolk QOL-DN) total score was assessed in 61 (stages 1-3) patients with TTR-FAP (V30M variant) and 16 healthy controls. Composite measures of large- and small-nerve fiber function, and modified body mass index (mBMI) were also assessed. ResultsOrdinal-based NIS-LL and Norfolk QOL-DN scores discriminated between disease stages (P<0.0001 for NIS-LL and Norfolk QOL-DN). Longer disease duration correlated with worse NIS-LL and Norfolk QOL-DN. Karnofsky performance score declined progressively by disease stage. Composite measures of nerve fiber function differentiated stage 1 from stage 2 disease. The mBMI declined with advancing disease. ConclusionsNIS-LL, Norfolk QOL-DN score, composite endpoints of nerve fiber function, and mBMI are valid, reliable measures of TTR-FAP severity. Muscle Nerve55: 323-332, 2017
引用
收藏
页码：323 / 332
页数：10
相关论文
共 50 条
  • [21] The diagnostic accuracy of Sudoscan in transthyretin familial amyloid polyneuropathy
    Castro, J.
    Miranda, B.
    Castro, I.
    Carvalho, M.
    Conceicao, I.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 23 - 24
  • [22] PATIENT CENTRICITY: SURVIVING TRANSTHYRETIN FAMILIAL AMYLOID POLYNEUROPATHY
    Coelho, T.
    Ines, M.
    Conceicao, I
    Saramago, P.
    Carvalho, M.
    Costa, J.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2016, 21 (03) : 244 - 244
  • [23] Update in the diagnosis and management of transthyretin familial amyloid polyneuropathy
    Violaine Plante-Bordeneuve
    Journal of Neurology, 2014, 261 : 1227 - 1233
  • [24] NUMBER OF TRANSTHYRETIN FAMILIAL AMYLOID POLYNEUROPATHY CASES IN BRAZIL
    Alexandre, R. F.
    Squiassi, H. B.
    Santana, C. F.
    VALUE IN HEALTH, 2017, 20 (05) : A212 - A212
  • [25] Presentations of transthyretin associated familial amyloid polyneuropathy in Argentina
    Chaves, Marcelo
    Bettini, Mariela
    Marciano, Sebastian
    Saez, Soledad
    Cristiano, Edgardo
    Rugiero, Marcelo
    MEDICINA-BUENOS AIRES, 2016, 76 (02) : 105 - 108
  • [26] Estimating the global prevalence of transthyretin familial amyloid polyneuropathy
    Schmidt, Hartmut H.
    Waddington-Cruz, Marcia
    Botteman, Marc F.
    Carter, John A.
    Chopra, Avijeet S.
    Hopps, Markay
    Stewart, Michelle
    Fallet, Shari
    Amass, Leslie
    MUSCLE & NERVE, 2018, 57 (05) : 829 - 837
  • [27] Serum transthyretin monomer in patients with familial amyloid polyneuropathy
    Sekijima, Y
    Tokuda, T
    Kametani, F
    Tanaka, K
    Maruyama, K
    Ikeda, S
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2001, 8 (04): : 257 - 262
  • [28] The diagnostic accuracy of Sudoscan in transthyretin familial amyloid polyneuropathy
    Castro, Jose
    Miranda, Bruno
    Castro, Isabel
    de Carvalho, Mamede
    Conceicao, Isabel
    CLINICAL NEUROPHYSIOLOGY, 2016, 127 (05) : 2222 - 2227
  • [29] LIFE EXPECTANCY AND COSTS OF TRANSTHYRETIN FAMILIAL AMYLOID POLYNEUROPATHY
    Ines, M.
    Coelho, T.
    Conceicao, I
    Saramago, P.
    Carvalho, M.
    Costa, J.
    VALUE IN HEALTH, 2017, 20 (09) : A553 - A553
  • [30] Update in the diagnosis and management of transthyretin familial amyloid polyneuropathy
    Plante-Bordeneuve, Violaine
    JOURNAL OF NEUROLOGY, 2014, 261 (06) : 1227 - 1233
12345